dipyridamole has been researched along with phenprocoumon in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bertuch, H; Decrinis, M; Krejs, GJ; Lammer, J; Pfeiffer, KP; Pilger, E; Stark, G | 1 |
| Burckhardt, D; Burkart, F; Jockers, G; Meyer, B; Müller-Brand, J; Pfisterer, M; Regenass, S; Schmitt, HE; Skarvan, K; Stulz, P | 1 |
| Burkart, F; Grädel, E; Jockers, G; Pfisterer, M; Regenass, S; Schmitt, HE | 1 |
| Pilger, E | 1 |
| Schröder, R | 1 |
| Beythien, C; Hamm, CW; Terres, W | 1 |
| Brutel de la Rivière, A; Dunselman, PH; Hillege, HL; Kootstra, GJ; Lie, KI; Mulder, BJ; Pfisterer, M; van der Meer, J; van Gilst, WH | 1 |
| Do, DD; Mahler, F | 1 |
| Dunning, AJ; Mulder, BJ; Piek, JJ; Tijssen, JG; van der Doef, RM; van der Meer, J; van der Wall, EE | 1 |
| Ascoop, CA; Hillege, HL; Kootstra, GJ; Lie, KI; Mulder, BJ; Pfisterer, M; van der Meer, J; van Gilst, WH | 1 |
| Deng, MC; Hammel, D; Nabavi, D; Scheld, HH; Schmid, C; Weyand, M | 1 |
| Hoffmann, MW; Rauhöft, C; Terres, W | 1 |
| Glogar, D; Gottsauner-Wolf, M; Hornykewycz, S; Huber, K; Maurer, G; Nikfardjam, M; Probst, P; Stepan, E; Wexberg, P; Zasmeta, G; Zorn, G | 1 |
| de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC | 1 |
| Hillege, HL; van der Meer, J; Veeger, NJ; Zijlstra, F | 1 |
| Hiratzka, LF | 1 |
1 review(s) available for dipyridamole and phenprocoumon
| Article | Year |
|---|---|
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors | 1981 |
10 trial(s) available for dipyridamole and phenprocoumon
| Article | Year |
|---|---|
Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results.
Topics: Aged; Angioplasty, Balloon; Angioplasty, Laser; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Female; Femoral Artery; Follow-Up Studies; Humans; Male; Phenprocoumon; Popliteal Artery; Recurrence; Time Factors | 1991 |
Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Topics: 4-Hydroxycoumarins; Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Premedication; Prospective Studies; Random Allocation; Saphenous Vein | 1989 |
[How long should antithrombotic therapy be continued following aortocoronary bypass surgery?].
Topics: 4-Hydroxycoumarins; Adult; Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Female; Humans; Male; Middle Aged; Phenprocoumon; Prospective Studies; Randomized Controlled Trials as Topic; Vascular Patency | 1989 |
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Inst
Topics: Acenocoumarol; Anticoagulants; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Phenprocoumon; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vascular Patency | 1994 |
Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty.
Topics: Administration, Oral; Aged; Angioplasty, Balloon; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Femoral Artery; Humans; Life Tables; Male; Phenprocoumon; Popliteal Artery; Prospective Studies; Radiography; Vascular Patency | 1994 |
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Exercise Test; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Phenprocoumon; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Saphenous Vein; Thallium Radioisotopes; Treatment Outcome | 1994 |
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Ne
Topics: Acenocoumarol; Administration, Oral; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Treatment Outcome; Vascular Patency | 1993 |
[Long term effects of 50 mg acetylsalicylic acid alone and in combination with dipyridamole on platelet function after coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thromboxane B2; Time Factors | 1998 |
Plasma levels of C-reactive protein after coronary stent implantation.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Prognosis; Stents; Ticlopidine | 2000 |
Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Vitamin K | 2010 |
6 other study(ies) available for dipyridamole and phenprocoumon
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Computer-assisted in vivo study of capillary permeability].
Topics: Adolescent; Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Aspirin; Capillary Permeability; Collagen Diseases; Computers; Cyanosis; Dipyridamole; Drug Therapy, Combination; Factor XIII; Female; Heparin; Humans; Male; Microcomputers; Middle Aged; Nails; Phenprocoumon; Raynaud Disease; Rheology; Streptokinase | 1985 |
In vitro model to test the thrombogenicity of coronary stents.
Topics: Adult; Aspirin; Biocompatible Materials; Coronary Thrombosis; Coronary Vessels; Dipyridamole; Heparin; Humans; Male; Partial Thromboplastin Time; Phenprocoumon; Platelet Aggregation; Prothrombin Time; Stainless Steel; Stents; Tantalum | 1994 |
Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100--preliminary results.
Topics: Anticoagulants; Aspirin; Case-Control Studies; Dipyridamole; Female; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Thromboembolism | 1998 |
Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K | 2008 |
Invited commentary.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Phenprocoumon; Vitamin K | 2010 |